Gender-differentiated pathways from childhood trauma to self-injury: rumination as a mediator in depressed adolescents

童年创伤到自残行为的性别差异路径:反刍思维在抑郁青少年中起中介作用

阅读:1

Abstract

BACKGROUND: Amid the global escalation of adolescent depression and non-suicidal self-injury (NSSI), childhood trauma has been identified as a critical risk factor, yet how specific trauma subtypes contribute to NSSI remains unclear. This study aims to explore the relationship between childhood trauma subtypes and NSSI in depressed adolescents, focusing gender differences, and verify the mediating role of rumination. METHODS: This cross-sectional study included 2,006 clinically depressed adolescents (aged 10-19), who were recruited through convenience sampling from a psychiatric hospital in China (2024-2025). Validated scales (Childhood Trauma Questionnaire [CTQ], Ruminative Response Scale [RRS], Ottawa Self-Injury Inventory [OSI]) were administered. Binary logistic regression, subgroup analysis, and mediation analysis were used to examine the relationships between variables. RESULTS: NSSI prevalence reached 69.3% in depressed adolescents (female: 77.6% vs. male: 52.1%). Emotional neglect (EN, odds ratio [OR] = 1.82), emotional abuse (EA, OR = 2.06), and physical abuse (PA, OR = 2.55) were associated with NSSI. Gender difference analysis revealed that females were more sensitive to EN (OR = 2.30) and EA (OR = 2.06), while males were more sensitive to EA (OR = 2.07) and PA (OR = 2.12). A single trauma subtype significantly increased the risk of NSSI in females, whereas males required at least two trauma subtypes to significantly increase NSSI risk. Rumination played a mediating role between all trauma subtypes and NSSI, with sexual abuse (SA) showing the highest mediation effect (78.02%), indicating a full mediation effect. CONCLUSIONS: The childhood trauma-NSSI association in depressed adolescents demonstrates gender difference, with rumination functioning as the central mechanistic pathway. Interventions must prioritize trauma subtype- and gender-tailored strategies to disrupt rumination pathways. CLINICAL TRIAL NUMBER: Not applicable.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。